DPB Pharmaceuticals

DPB group of enterprises, DPB Antibiotics was founded in 2005 with the objective of providing the expanding pharmaceutical sector with high-quality API’s. Leveraging extensive experience and industry insights, we are well-equipped to meet the industry’s demands. Our specialization lies in the supply of pharmaceutical APIs, Excipients & FDF. Our headquarters are located in Mumbai, India, with branch offices in China. DPB has achieved significant success by supplying to over 1200 customers within India and more than 300 customers across 40 countries in the international market. We have strong ties with many Indian manufacturers for API supplies, in addition to imports from various countries. The company's exceptional management and customer relationships have driven our turnover to $125 million. We proudly hold the title of the largest manufacturer & exporter of Isoxazoles group of APIs in the world, with the capacity to produce approximately 800 MT per annum. Furthermore, we possess the largest installed capacity in the country to manufacture high-quality oral enzymatic antibiotic APIs, with an annual capacity of around 1400 MT. DPB group has plans to increase this capacity to about 2000 MT per annum. Our plant complies with regulatory USFDA/EU-GMP guidelines. Moreover, we are the sole manufacturer of the key antibiotic Amoxicillin - Potassium Clavulanate Sterile (5:1 Mixture) with proprietary technology in India. We are also aiming to fully utilize the 180 MT per annum capacity by adding high-value products like meropenam sterile. The quality of our API sets our company apart, making it a unique brand in the industry.